DPI to set up FIH unit at Phoenix hospital

By Gareth Macdonald

- Last updated on GMT

Related tags Clinical trial

US CRO Dedicated Phase I (DPI) says plan to set up first in human (FIH) unit at Phoenix hospital reflects growing drug industry demand for studies in this setting.

CEO Jason Bonanza told Outsourcing-pharma that: “We have seen some of our major Sponsors move trials to hospital-based units overseas, mostly with biologics. Our goal is to meet the strictest demands when it comes to safety in FIH trials.”

The deal, details of which have not yet been announced, is part of an exclusive agreement with Integrated Medical Services (IMS), a network of 128 multi-specialty physicians with 41 offices in 13 Arizona cities.

Partnering with a hospital and IMS are both steps toward establishing a wider network of resources that are the basis for providing more efficient and cost effective services to our pharmaceutical sponsors​.”

Bonanza added that DPI is working to design an advantageous floor plan within the hospital, and the first hospital-based studies are expected to begin at the additional site in 2012.

Phase I flexibility

Bonanza also contrasted DPI’s plan with the trend that has seen a number of contract research organizations (CRO), most recently​ Charles River Laboratories (CRL), move to reduce FIH capacity.

Phase I sites that are part of a larger organization often lack the flexibility and drive to anticipate the ever-changing customer needs and are slow to respond to new challenges proactively, without losing efficiency and data integrity.

He went on to explain that “In a tough economy and a highly competitive industry, understanding customer needs and future trends is absolutely essential to forging strong relationships and ensuring repeat business, which is why we’re so excited about this new partnership.”

The global recession has affected the entire industry, DPI included, but we’ve already seen a significant uptick in contracts and revenues in 2010, and the projections for 2011 are increasingly optimistic​.”

When operational the hospital unit will work with DPI’s existing 70-bed clinical research facility which is also based in Phoenix.

Related news

Show more

Related products

show more

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

Validate clinical study data with Formedix CORE

Validate clinical study data with Formedix CORE

Content provided by Formedix | 19-Jun-2023 | White Paper

In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

Related suppliers

Follow us


View more